Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

8.610 +0.270 (+3.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,770,520
Open 9.900
Bid (Size) 8.600 (1,900)
Ask (Size) 8.610 (17,100)
Prev. Close 8.340
Today's Range 8.470 - 9.980
52wk Range 6.320 - 55.57
Shares Outstanding 33,981,877
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Wondering what's happening in today's after-hours session?
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill

Performance

YTD
-75.1%
-75.1%
1 Month
+1.4%
+1.4%
3 Month
+14.0%
+14.0%
6 Month
-42.2%
-42.2%
1 Year
-83.4%
-83.4%

More News

Read More
RxSight, Inc. Reports Third Quarter 2025 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Earnings Scheduled For November 5, 2025
Via Benzinga
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
Via MarketMinute
Topics Earnings Supply Chain
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating RxSight, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi, LLP
Via Business Wire
RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Urges RXST To Contact the Firm Regarding Class Action Lawsuit
From Bragar Eagel & Squire
Via GlobeNewswire
RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST
Via NewMediaWire
Topics Fraud Lawsuit
RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi LLP
Via GlobeNewswire
Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
RXSIGHT DEADLINEALERT: Bragar Eagel & Squire, P.C. Reminds RXST Investors that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm Before September 22nd
From Bragar Eagel & Squire
Via GlobeNewswire
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi LLP
Via GlobeNewswire
RXSIGHT DEADLINEALERT: Bragar Eagel & Squire, P.C. Reminds RXST Investors that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm Before September 22nd
From Bragar Eagel & Squire
Via GlobeNewswire
RXST DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – RXST
From The Rosen Law Firm PA
Via GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against RxSight, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?
Yes, RxSight, Inc. - Common Stock is publicly traded.
What exchange does RxSight, Inc. - Common Stock trade on?
RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RxSight, Inc. - Common Stock?
The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market
What is the current price of RxSight, Inc. - Common Stock?
The current price of RxSight, Inc. - Common Stock is 8.610
When was RxSight, Inc. - Common Stock last traded?
The last trade of RxSight, Inc. - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of RxSight, Inc. - Common Stock?
The market capitalization of RxSight, Inc. - Common Stock is 292.58M
How many shares of RxSight, Inc. - Common Stock are outstanding?
RxSight, Inc. - Common Stock has 293M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.